These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 11249710)

  • 21. N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymerase.
    Yin Z; Chen YL; Kondreddi RR; Chan WL; Wang G; Ng RH; Lim JY; Lee WY; Jeyaraj DA; Niyomrattanakit P; Wen D; Chao A; Glickman JF; Voshol H; Mueller D; Spanka C; Dressler S; Nilar S; Vasudevan SG; Shi PY; Keller TH
    J Med Chem; 2009 Dec; 52(24):7934-7. PubMed ID: 20014868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus NS5B polymerase exhibits distinct nucleotide requirements for initiation and elongation.
    Ferrari E; He Z; Palermo RE; Huang HC
    J Biol Chem; 2008 Dec; 283(49):33893-901. PubMed ID: 18840605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Possible functional role of the DD-domain of RNA-dependent polymerases].
    Zavriev SK; Borisova OV
    Mol Biol (Mosk); 1987; 21(1):229-41. PubMed ID: 2437438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus.
    Bressanelli S; Tomei L; Roussel A; Incitti I; Vitale RL; Mathieu M; De Francesco R; Rey FA
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13034-9. PubMed ID: 10557268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elongation of synthetic RNA templates by hepatitis C virus NS5B polymerase.
    Liu C; Chopra R; Swanberg S; Olland S; O'Connell J; Herrmann S
    J Biol Chem; 2004 Mar; 279(11):10738-46. PubMed ID: 14688285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and functional analysis of hepatitis C virus strain JFH1 polymerase.
    Simister P; Schmitt M; Geitmann M; Wicht O; Danielson UH; Klein R; Bressanelli S; Lohmann V
    J Virol; 2009 Nov; 83(22):11926-39. PubMed ID: 19740982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical characterization of rhinovirus RNA-dependent RNA polymerase.
    Hung M; Gibbs CS; Tsiang M
    Antiviral Res; 2002 Nov; 56(2):99-114. PubMed ID: 12367717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting structural dynamics of the RNA-dependent RNA polymerase for anti-viral strategies.
    Boehr DD; Liu X; Yang X
    Curr Opin Virol; 2014 Dec; 9():194-200. PubMed ID: 25224392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of HCV RdRp activity with C-terminal 21 aa truncated NS5b protein: optimization of assay conditions.
    Uchiyama Y; Huang Y; Kanamori H; Uchida M; Doi T; Takamizawa A; Hamakubo T; Kodama T
    Hepatol Res; 2002 Jun; 23(2):90-97. PubMed ID: 12048062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus RNA-dependent RNA polymerase: study on the inhibition mechanism by pyrogallol derivatives.
    Kozlov MV; Polyakov KM; Ivanov AV; Filippova SE; Kuzyakin AO; Tunitskaya VL; Kochetkov SN
    Biochemistry (Mosc); 2006 Sep; 71(9):1021-6. PubMed ID: 17009957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Stimulatory Mechanism of Hepatitis C Virus NS5A Protein on the NS5B Catalyzed Replication Reaction In Vitro.
    Quezada EM; Kane CM
    Open Biochem J; 2013; 7():11-4. PubMed ID: 23407362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etodolac Thiosemicarbazides: A novel class of hepatitis C virus NS5B polymerase inhibitors.
    Çıkla P; Arora P; Basu A; Talele TT; Kaushik-Basu N; Küçükgüzel ŞG
    Marmara Pharm J; 2013; 17():138-146. PubMed ID: 30948924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections.
    Beaulieu PL
    Curr Opin Investig Drugs; 2007 Aug; 8(8):614-34. PubMed ID: 17668364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of ligands that target the HCV-E2 binding site on CD81.
    Olaby RA; Azzazy HM; Harris R; Chromy B; Vielmetter J; Balhorn R
    J Comput Aided Mol Des; 2013 Apr; 27(4):337-46. PubMed ID: 23612915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The respiratory syncytial virus polymerase has multiple RNA synthesis activities at the promoter.
    Noton SL; Deflubé LR; Tremaglio CZ; Fearns R
    PLoS Pathog; 2012; 8(10):e1002980. PubMed ID: 23093940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of host metabolism as a target of new antivirals.
    Ikeda M; Kato N
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1277-89. PubMed ID: 17897752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in the analysis of HCV NS5B RNA-dependent RNA polymerase.
    Lesburg CA; Radfar R; Weber PC
    Curr Opin Investig Drugs; 2000 Nov; 1(3):289-96. PubMed ID: 11249710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A homogeneous, solid-phase assay for hepatitis C virus RNA-dependent RNA polymerase.
    Wang YK; Rigat KL; Roberts SB; Gao M
    Anal Biochem; 2006 Dec; 359(1):106-11. PubMed ID: 17054898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificity and mechanism analysis of hepatitis C virus RNA-dependent RNA polymerase.
    Johnson RB; Sun XL; Hockman MA; Villarreal EC; Wakulchik M; Wang QM
    Arch Biochem Biophys; 2000 May; 377(1):129-34. PubMed ID: 10775451
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.